Investor Alert

New York Markets After Hours

Market Pulse Archives

March 19, 2021, 6:49 a.m. EDT

Elanco stands by safety of Seresto collars, which remain available despite calls for removal from market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Elanco Animal Health Inc. (ELAN)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Elanco Animal Health Inc. /zigman2/quotes/203710302/composite ELAN -1.23% said Friday that it stands behind the safety of the Seresto flea collars, which a U.S. House of Representatives subcommittee chair requested be temporarily removed from the market after a recent "misleading" media report. The animal health and care company said all data and scientific evaluation used during the company's review of the product supported its safety profile, so Elanco has said it will take no market action, such as a recall, and the product will remain available across the U.S. and the world. A March 2 report by the Midwest Center for Investigative Reporting and USA Today said the Seresto flea collar was linked to at least about 1,700 pets since the collars were introduced in 2012. "There is no medical or scientific basis to initiate a recall of Seresto collars and we are disappointed this is causing confusion and unfounded fear for pet owners trying to protect their pets from fleas and ticks," said Dr. Tony Rumschlag, senior director for Technical Consultants at Elanco. "The recent media reports were based on raw data and cannot be used to draw conclusions on what may have actually caused the issues." Elanco's stock, which was still inactive in premarket trading, has rallied 10.0% year to date while the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.98% has gained 4.2%.

$ 32.90
-0.41 -1.23%
Volume: 3.75M
Oct. 28, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$15.76 billion
Rev. per Employee
+44.74 +0.98%
Volume: 2.15B
Oct. 28, 2021 4:20p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.